Clinical trial
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III…
NCT00003018 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003018 |
|---|---|
| Title | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer |
| Official title | A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients With Locally Advanced Unresected Pancreatic Adenocarcinoma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | dipyridamole, fluorouracil, leucovorin calcium, mitomycin C |
| Enrollment | 54 |
| Start date | Sep 1, 1997 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2007 |
| First posted | Apr 22, 2004 |
| Last update posted | Jan 3, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: